Lymphocyte activation gene 3 (Lag3) supports Foxp3+ Treg cell function by restraining c-Myc-dependent aerobic glycolysis
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA938482 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Lymphocyte activation gene 3 (Lag3) has emerged as the next-generation immune checkpoint molecule due to its ability to inhibit effector T cell activity. Foxp3+ regulatory T (Treg) cells, a master regulator of immunity and tolerance, also highly express Lag3. While Lag3 is thought to be necessary for Treg cell-mediated regulation of immunity, the precise roles and underlying mechanisms remain largely elusive. In this study, we report that Lag3 is indispensable for Treg cells to control autoimmune inflammation. Utilizing a newly generated Treg cell specific Lag3 mutant mouse model, we found that these animals are highly susceptible to autoimmune diseases, suggesting defective Treg cell function. Genome wide transcriptome analysis further uncovered that Lag3 mutant Treg cells upregulated genes involved in metabolic processes. Mechanistically, we found that Lag3 limits Treg cell expression of Myc, a key regulator of aerobic glycolysis. We further found that Lag3-dependent Myc expression determines Treg cells’ metabolic programming as well as the in vivo function to suppress autoimmune inflammation. Taken together, our results uncovered a novel function of Lag3 in supporting Treg cell suppressive function by regulating Myc-dependent metabolic programming.
2024-08-30 | GSE226083 | GEO
Project description:CD8+ T cell exhaustion is a distinct differentation state resulting from chronic antigen exposure and leading to hierarchical loss of effector functions. Using a murine model of diabetes, we show that CD8+ T cells derived from the islets of diabetic mice have CD8+ T cells that are canonically exhausted and yet retain sufficient effector function to contribute to pathogenicity in autoimmune diabetes. Genetic deletion of the inhibitory receptor LAG3 restricted to only CD8+ T cells lead to accelerated disease, with LAG3 deficient CD8+ T cells having enhanced effector function and trafficking. These findings reveal a distinct role of LAG3 in restraining autoreactive CD8+ T cells and implicate LAG3 as a potential therapeutic target in autoimmunity.
2022-04-08 | GSE199357 | GEO
Project description:1. The role of enhanced aerobic glycolysis in the transformation of rat thymocytes by concanavalin A has been investigated. Concanavalin A addition doubled [U-(14)C]glucose uptake by rat thymocytes over 3h and caused an equivalent increased incorporation into protein, lipids and RNA. A disproportionately large percentage of the extra glucose taken up was converted into lactate, but concanavalin A also caused a specific increase in pyruvate oxidation, leading to an increase in the percentage contribution of glucose to the respiratory fuel. 2. Acetoacetate metabolism, which was not affected by concanavalin A, strongly suppressed pyruvate oxidation in the presence of [U-(14)C]glucose, but did not prevent the concanavalin A-induced stimulation of this process. Glucose uptake was not affected by acetoacetate in the presence or absence of concanavalin A, but in each case acetoacetate increased the percentage of glucose uptake accounted for by lactate production. 3. [(3)H]Thymidine incorporation into DNA in concanavalin A-treated thymocyte cultures was sensitive to the glucose concentration in the medium in a biphasic manner. Very low concentrations of glucose (25mum) stimulated DNA synthesis half-maximally, but maximum [(3)H]thymidine incorporation was observed only when the glucose concentration was raised to 1mm. Lactate addition did not alter the sensitivity of [(3)H]-thymidine uptake to glucose, but inosine blocked the effect of added glucose and strongly inhibited DNA synthesis. 4. It is suggested that the major function of enhanced aerobic glycolysis in transforming lymphocytes is to maintain higher steady-state amounts of glycolytic intermediates to act as precursors for macromolecule synthesis.
| S-EPMC1185973 | biostudies-other
Project description:Comparison of gene expression profile of CD4+ CD25+, CD4+ CD25- CD45RBlow LAG3+ and CD4+ CD25- CD45RBlow LAG3- T cells. Naive CD4+CD25-CD45RBhigh T cells were used as a reference for pair comparison with values from the three other subsets.
2009-08-19 | E-MEXP-1343 | biostudies-arrayexpress
Project description:Rattus norvegicus Lag3, lymphocyte activating 3 [Source:RGD Symbol;Acc:1302990], is expressed in 3 baseline experiment(s);
| ENSRNOG00000021334 | ExpressionAtlas
Project description:Rattus norvegicus Lag3, lymphocyte activating 3 [Source:RGD Symbol;Acc:1302990], is differentially expressed in 1 experiment(s);
| ENSRNOG00000021334 | ExpressionAtlas
Project description:Macaca mulatta LAG3, lymphocyte activating 3 [Source:HGNC Symbol;Acc:HGNC:6476], is expressed in 2 baseline experiment(s);
| ENSMMUG00000056979 | ExpressionAtlas
Project description:Oryctolagus cuniculus LAG3, lymphocyte activating 3 [Source:HGNC Symbol;Acc:HGNC:6476], is expressed in 1 baseline experiment(s);
| ENSOCUG00000011196 | ExpressionAtlas
Project description:Homo sapiens LAG3, lymphocyte activating 3 [Source:HGNC Symbol;Acc:HGNC:6476], is expressed in 39 baseline experiment(s);
| ENSG00000089692 | ExpressionAtlas
Project description:Sus scrofa LAG3, lymphocyte activating 3 [Source:VGNC Symbol;Acc:VGNC:89617], is differentially expressed in 3 experiment(s);
| ENSSSCG00000000688 | ExpressionAtlas